v3.26.1
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 105
Cost of revenues (103)
Gross profit 2
Research and development, net (1,293) (1,459)
Sales, general and administrative (3,029) (1,562)
Operating loss (4,320) (3,021)
Other income (see Note 3F) 316
Financing income, net 649 104
Net loss $ (3,671) $ (2,601)
Basic net loss per share $ (0.05) $ (0.08)
Diluted net loss per share $ (0.05) $ (0.08)
Basic weighted average common shares outstanding 67,158,044 31,085,606
Diluted weighted average common shares outstanding 67,158,044 31,085,606